SFP
SLXP

Santa Fe Partners’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Santa Fe Partners’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,237
Closed -$522K – 664
2014
Q2 		$522K Buy
+4,237
New +$468K 0.08% 366
2014
Q1 		– Sell
-7,580
Closed -$682K – 648
2013
Q4 		$682K Sell
7,580
-20,447
-73% -$1.63M 0.11% 308
2013
Q3 		$1.88M Buy
+28,027
New +$1.93M 0.36% 117

Other funds holding SLXP

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Santa Fe Partners's SLXP Position: Q3 2014 in Review

Santa Fe Partners sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q3 2014, closing a stake of 4,237 shares — an estimated $522K sold.

Santa Fe Partners first reported a position in SLXP in Q3 2013 and held it in 3 quarters. The position peaked at $1.88M in Q3 2013. 348 funds tracked by Wall St. Rank hold SLXP as of Q3 2014.

  • Santa Fe Partners reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q3 2014 after selling out during the quarter.
  • Santa Fe Partners sold 4,237 SALIX PHARMACEUTICALS LTD DEL shares in Q3 2014, an estimated $522K.
  • Santa Fe Partners first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2013 and held it in 3 quarters.
  • Santa Fe Partners's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.88M in Q3 2013.
  • 348 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q3 2014.

Based on Santa Fe Partners's 13F filing for Q3 2014, filed 12 Nov 2014.